Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Orphan Medical begins Treatment IND trial of Xyrem in narcolepsy

Feb. 25, 1999

Apollo and AHP to develop estrogen products for Alzheimer's therapy

Feb. 24, 1999

Soluble peptide complex AG-284 is well tolerated in MS patients

Feb. 24, 1999

Combination pharmaco- and psychotherapy reduces recurrence of depression in elderly

Feb. 24, 1999

Synthelabo patents potent and selective nAChR ligands

Feb. 24, 1999

New combination treatment for pain now available in U.S.

Feb. 23, 1999

V2 antagonist OPC-31260 prevents cerebral edema in rat model

Feb. 23, 1999

Dopamine D3 ligands in the BASF pipeline

Feb. 23, 1999

Novel heterocyclic CRF antagonists under study at DuPont

Feb. 23, 1999

Ceresine shows positive results in phase II trial in stroke patients

Feb. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...